Table 5. Outcomes of patients who... | American Society of Hematology

Table 5.

Outcomes of patients who responded to bridging therapy

Response to bridging	Patient number	Systemic response	CNS response	PFS, mo	OS, mo
CR	Patient 10	CR (day 30)	Yes (day 30)	9.7	12.1
VGPR	Patient 7	VGPR (day 30) sCR (6 mo)	Yes (day 30)	6.3	13.3
PR	Patient 8	VGPR (day 30) sCR (6 mo)	Yes (day 30)	8	33.4
PR	Patient 2	CR (day 30)	Yes (day 90)∗	6.3†	6.3†

Response to bridging	Patient number	Systemic response	CNS response	PFS, mo	OS, mo
CR	Patient 10	CR (day 30)	Yes (day 30)	9.7	12.1
VGPR	Patient 7	VGPR (day 30) sCR (6 mo)	Yes (day 30)	6.3	13.3
PR	Patient 8	VGPR (day 30) sCR (6 mo)	Yes (day 30)	8	33.4
PR	Patient 2	CR (day 30)	Yes (day 90)∗	6.3†	6.3†

First CNS response assessment after CAR T-cell therapy was done at day 90, with no available data at day 30.

Patient achieved CR but died without progression at 6.3 months due to fatal sepsis.